Literature DB >> 18620894

Umami taste dysfunction in patients receiving radiotherapy for head and neck cancer.

Hideomi Yamashita1, Keiichi Nakagawa, Yoshio Hosoi, Azusa Kurokawa, Yusuke Fukuda, Ichiro Matsumoto, Takumi Misaka, Keiko Abe.   

Abstract

Taste loss is a major cause of morbidity in patients undergoing head and neck irradiation. Previous studies have reported the alteration of the four basic tastes in patients with head and neck cancer during radiotherapy. However, only a few studies have been conducted on the effects of irradiation on the function of umami taste, a novel and basic taste recently recognized. In a prospective study, 52 patients undergoing radical head and neck irradiation were assessed for taste loss. Taste ability was measured by the taste threshold for umami quality using the whole-mouth taste method in patients before, during, and immediately after radiotherapy. Umami taste declined of the 3rd week after the start of radiotherapy and improved of the 8th week.

Entities:  

Mesh:

Year:  2008        PMID: 18620894     DOI: 10.1016/j.oraloncology.2008.04.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

Review 1.  Understanding the impact of taste changes in oncology care.

Authors:  Joel B Epstein; Gregory Smutzer; Richard L Doty
Journal:  Support Care Cancer       Date:  2016-01-28       Impact factor: 3.603

2.  Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study.

Authors:  Mariana Henriques Ferreira; Leticia Mello Bezinelli; Fernanda de Paula Eduardo; Roberta Marques Lopes; Andrea Z Pereira; Nelson Hamerschlack; Luciana Corrêa
Journal:  Support Care Cancer       Date:  2019-06-24       Impact factor: 3.603

3.  Taste disorders following cancer treatment: report of a case series.

Authors:  Joel B Epstein; Safira Marques de Andrade E Silva; Geena L Epstein; Jorge Henrique Santos Leal; Andrei Barasch; Gregory Smutzer
Journal:  Support Care Cancer       Date:  2019-03-29       Impact factor: 3.603

4.  Mechanisms of taste bud cell loss after head and neck irradiation.

Authors:  Ha M Nguyen; Mary E Reyland; Linda A Barlow
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

5.  Lactoferrin supplementation for taste and smell abnormalities among patients receiving cancer chemotherapy.

Authors:  Glenn J Lesser; Megan B Irby; Richard C Taylor; Anna Snavely; Douglas Case; Aili Wang; Andrea Dietrich; Susan Duncan
Journal:  Support Care Cancer       Date:  2021-10-13       Impact factor: 3.359

Review 6.  Oral Health Management and Rehabilitation for Patients with Oral Cancer: A Narrative Review.

Authors:  Yuhei Matsuda; Ruwan D Jayasinghe; Hui Zhong; Shinichi Arakawa; Takahiro Kanno
Journal:  Healthcare (Basel)       Date:  2022-05-23

7.  Influence of smoking history on the perception of radiation-induced dysgeusia/hypogeusia in patients with head and neck cancer.

Authors:  DaMin Park; Shruti Jain; Zachary Quay-De La Vallee; Kathryn Huber; Miriam O'Leary; Arwa M Farag
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-31       Impact factor: 2.503

8.  Inhibition of SIRT1 promotes taste bud stem cell survival and mitigates radiation-induced oral mucositis in mice.

Authors:  Qiang Guo; Shengzhi Chen; Xinxin Rao; Yuanchuang Li; Mengxue Pan; Guoxiang Fu; Ye Yao; Xiaoxue Gao; Peiyuan Tang; Yi Zhou; Xiaoya Xu; Jianjun Gao; Guoqiang Hua
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 9.  Radiation-Related Alterations of Taste Function in Patients With Head and Neck Cancer: a Systematic Review.

Authors:  Tanaya S Deshpande; Pierre Blanchard; Li Wang; Robert L Foote; Xiaodong Zhang; Steven J Frank
Journal:  Curr Treat Options Oncol       Date:  2018-11-09

Review 10.  Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis.

Authors:  Herve Y Sroussi; Joel B Epstein; Rene-Jean Bensadoun; Deborah P Saunders; Rajesh V Lalla; Cesar A Migliorati; Natalie Heaivilin; Zachary S Zumsteg
Journal:  Cancer Med       Date:  2017-10-25       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.